iRadimed
IRMD
62 hedge funds and large institutions have $44.3M invested in iRadimed in 2016 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 27 increasing their positions, 13 reducing their positions, and 12 closing their positions.
108% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 13
17% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 12
3.58% more ownership
Funds ownership: 20.74% → 24.32% (+3.6%)
3% more funds holding
Funds holding: 60 → 62 (+2)
8% less capital invested
Capital invested by funds: $48.2M → $44.3M (-$3.9M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCA
Conestoga Capital Advisors
Wayne,
Pennsylvania
|
+$5.28M |
| 2 |
GPGA
Grandeur Peak Global Advisors
Salt Lake City,
Utah
|
+$1.98M |
| 3 |
MIP
Mondrian Investment Partners
London,
United Kingdom
|
+$1.06M |
| 4 |
Renaissance Technologies
New York
|
+$850K |
| 5 |
SIM
Spark Investment Management
New York
|
+$667K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIC
AWM Investment Company
New York
|
-$2.07M |
| 2 |
TCM
Timpani Capital Management
Milwaukee,
Wisconsin
|
-$1.63M |
| 3 |
EA
Emerald Acquisition
Seattle,
Washington
|
-$1.01M |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$595K |
| 5 |
AR
Advisory Research
Chicago,
Illinois
|
-$556K |
IRMD Hedge Fund Activity: Q3 2016 in Review
62 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in iRadimed (IRMD) for Q3 2016, worth a combined $44.3M — down 8.1% from $48.2M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new IRMD positions and 12 closed out — a net gain of 2 holders — while 27 added to existing stakes and 13 trimmed.
The largest buyer was Conestoga Capital Advisors, adding an estimated $5.28M. The largest seller was AWM Investment Company, cutting an estimated $2.07M.
- 62 institutional investors held iRadimed (IRMD) as of Q3 2016, up from 60 in Q2 2016.
- Funds reported $44.3M of iRadimed stock for Q3 2016, down 8.1% quarter-over-quarter.
- 14 funds opened new iRadimed positions in Q3 2016 and 12 closed out, a net change of +2 holders.
- The largest iRadimed buyer in Q3 2016 was Conestoga Capital Advisors, an estimated $5.28M added.
- The largest iRadimed seller in Q3 2016 was AWM Investment Company, an estimated $2.07M sold.
Based on aggregated 13F filings for Q3 2016.